Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (QNTM) analyst actions
Rating and price-target actions on QNTM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the QNTM overview →
4 measured QNTM analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target | Press release | +1.79% | +2.48% | |
| Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status | Press release | +9.12% | +35.90% | |
| Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target | Press release | -0.68% | +22.87% | |
| Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 | Press release | -0.96% | -13.05% |
Keep exploring
More QNTM: earnings → · SEC filings → · QNTM overview →